Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/5/2010

SAN DIEGO, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2010.

On November 2, Cadence announced that the U.S. Food and Drug Administration (FDA) approved OFIRMEV™ (acetaminophen) injection for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.

"We believe that there is a clear need for OFIRMEV in the U.S., as the classes of IV analgesics available to treat acute pain – opioids and NSAIDS – are associated with significant side effects. OFIRMEV is an important new treatment option that provides patients with significant pain relief while reducing opioid consumption," said Ted Schroeder, President and CEO of Cadence. "The approval of OFIRMEV marks Cadence's transition into a commercial enterprise poised to support the successful launch of our first product early in the first quarter of 2011."

Financial ResultsFor the three months ended September 30, 2010, Cadence reported a net loss of $11.7 million, or $0.23 per share, compared to a net loss of $11.4 million, or $0.23 per share, for the comparable period in 2009. For the nine months ended September 30, 2010, Cadence reported a net loss of $37.9 million, or $0.75 per share, compared to a net loss of $30.2 million, or $0.63 per share, for the comparable period in 2009.

Operating expenses for the three months ended September 30, 2010 decreased $0.2 million to $11.1 million, from the $11.3 million reported for the same period in 2009. This decrease was primarily a result of lower research and development spending and ge
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014  Marta Rendon, MD, founder of the Rendon Center ... , FL and international key opinion leader in dermatology, was one ... United States to attend the international Aesthetic Experts ... . Here, at this gathering of over 600 physicians from ... plastic surgery experts from Asia and ...
(Date:11/24/2014)... , Nov. 24, 2014  Surgical Theater, LLC, announced ... November 24 th opening of Europe,s ... Neurologico Nazionale "C. Besta." The SuRgical Planner (SRP) and ... at the event for their 3D navigation and augmented ... Joshua Bederson , Professor and Chair, Department of Neurosurgery ...
(Date:11/24/2014)... England , Nov. 24, 2014  Pifflers ... https://www.facebook.com/PifflersUnited announced the release of results of ... therapy device, in the self-management of fibromyalgia pain. ... area of worst pain, very significant clinically meaningful ... The 140 group members with fibromyalgia used ActiPatch® ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3
... ASTRO Booth # 825 – At the American ... 2-6 in Miami Beach, Fla., Elekta will highlight its ... processes involved in radiation therapy, inspiring confidence in healthcare ... techniques are becoming increasingly sophisticated, requiring more time and ...
... Sept. 26, 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: ... a company that discovers and develops new uses for ... announced positive results from a 12-week open label extension ... Phase III trials for Zertane™ in patients with premature ...
Cached Medicine Technology:Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 2Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 3Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation. 2Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation. 3
(Date:11/24/2014)... The typical American diet includes foods that ... consuming a diet high in calories and carbohydrates only ... that typically accumulate around the internal organs exposing people ... in the form of love handles, beer bellies and ... to rid themselves of the burden of embarrassing, unhealthy ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 ReAdmission ... and disease management services to health plans, hospitals, ... Essette’s Medical Management software suite. ReAdmission Solutions ... in a program to reduce patients' avoidable readmissions ... Health Management, Care Management, Utilization Management, and Appeals ...
(Date:11/24/2014)... 2014 Dr. Michael Kettel , a ... appeared on NBC to discuss egg freezing as a viable ... trending in the news recently, with new company benefits at ... , “[The companies] see it as a way ... career hot path.” Says Dr. Kettel. , Up until a ...
(Date:11/23/2014)... November 24, 2014 The clinical ... 2014" provides data on the Aspergillosis clinical trial ... relating to the clinical trials on Aspergillosis. It ... their recruitment status as per the site of ... a preliminary coverage of disease clinical trials by ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
Breaking Medicine News(10 mins):Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... The bird flu fears in Greece may lead to collapse of ... over 15,000 people and produces almost 1.5 billion eggs a year.//, ... in chickens; there have been 19 confirmed cases that were reported ... or bird flu among consumers has been seen not only in ...
... twins have been successfully separated by Saudi Arabian doctors. The ... Riyadh separated the conjoined twin girls, reported the Saudi Press ... conjoined abdomen and shared a common urinary tract and hip. ... that the fifth, most critical stage in the operation had ...
... of the H5N1 viral strain in a wild goose in ... infection to the sixth German state has been confirmed//. The ... is at significant risk of a dangerous epidemic. ... of where the bird was found as tests were under ...
... death of Anita Louise, a participant of the experimental multiple ... focus by two neurologists from Stanford University//. The authors warn ... the adverse effects of the experimental drug is unknown. ... granted fast track status by the FDA in 2004. Soon ...
... Forrest City, Ark has been closed on by ,Brentwood-based ... is 118-bedded would be leased from its owner (St. ... assets would be acquired from the former operator of ... Corp.) The newly acquired hospital would be called as ...
... a well designed community campaign can dramatically cut marijuana and ... 32 schools in 16 communities around the country.// As a ... began using marijuana and alcohol during the two years of ... communities without the program. , Michael Slater, principal ...
Cached Medicine News:Health News:Multiple Sclerosis Drug Trial Criteria to Be Redefined 2Health News:Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum 2
... with 955R Red/Green glasses is a ... binocular vision. Consists of a black ... green, one red and one white. ... Patient wears red/green glasses which makes ...
20 foot distance 22-1/2" X 11-1/2". This test for illiterate patients has HOTV letters on one side and Allen figures on the other....
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
McIntyre-Binkhorst, length 18 mm....
Medicine Products: